Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20070309Description: 204-11 p. digitalISSN:- 0165-5728
- Adjuvants, Immunologic -- therapeutic use
- Adult
- CD4-Positive T-Lymphocytes -- metabolism
- Cohort Studies
- Female
- Glucocorticoid-Induced TNFR-Related Protein
- Humans
- In Vitro Techniques
- Interferon beta-1a
- Interferon-beta -- therapeutic use
- Interleukin-2 Receptor alpha Subunit -- metabolism
- Longitudinal Studies
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- blood
- Receptors, Nerve Growth Factor -- metabolism
- Receptors, Tumor Necrosis Factor -- metabolism
- T-Lymphocyte Subsets -- pathology
- T-Lymphocytes, Regulatory -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.